Detalhe da pesquisa
1.
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
Pharmacol Res
; 123: 40-50, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28648738
2.
Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.
Mol Pharmacol
; 88(3): 488-501, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26121982
3.
The non-biphenyl-tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor.
Br J Pharmacol
; 175(12): 2454-2469, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570771
4.
Activation of G-protein-coupled receptors: a common molecular mechanism.
Trends Endocrinol Metab
; 14(9): 431-7, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14580763
5.
Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response.
Proc Natl Acad Sci U S A
; 103(50): 19087-92, 2006 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17148616
6.
"Network leaning" as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists.
J Biol Chem
; 279(15): 15248-57, 2004 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-14754891
7.
Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine.
J Am Soc Nephrol
; 12(1): 29-36, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11134247